FDA requires black box warnings on labeling for botulinum toxin products.
Kuehn
Bridget M
BM
D001905:Botulinum Toxins / Q000009:adverse effects*; D004348:Drug Labeling; D006801:Humans; D012306:Risk; D014481:United States; D014486:United States Food and Drug Administration
D001905:Botulinum Toxins